Patrick Mooney

Director Ejecutivo en SPYGLASS PHARMA, INC. .

Fortuna: 4 M $ al 31/05/2026

52 años

Health Technology

Perfil

Patrick Mooney has been serving as Chief Executive Officer & Director at SpyGlass Pharma, Inc. since 2021.
This is the current job.

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
SPYGLASS PHARMA, INC. 0,55 %	06/02/2026	183.153 ( 0,55 % )	4 M $	31/05/2026

Empresas	Cargo	Inicio
SPYGLASS PHARMA, INC.	Director Ejecutivo	01/07/2021

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	1
SpyGlass Pharma Inc SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients	Health Technology